Ultrasound (US) plays a critical role in the evaluation, treatment, screening, and surveillance of thyroid malignancy in pediatric patients. This review aims to summarize recent advances in this topic. Improvements in imaging technology have amplified the advantage of US and US-guided fine-needle aspiration biopsy for thyroid nodule evaluation, cancer diagnosis, and surgical planning. Ultrasound has a definitive screening role for early cancer detection in high-risk patients, including those with a history of radiation exposure from childhood treatments, environmental radiation disasters, or hereditary/familial cancer syndromes. Finally, US is a key component of lifelong surveillance for recurrence among pediatric thyroid cancer survivors.
U ltrasound (US) plays a critical role in the evaluation of the pediatric patient with suspected thyroid malignancy. With the advent of improved technologies, greater characterization of specific anatomic features associated with benign and cancerous nodules is now possible. 1 One-tenth of thyroid cancers occur in patients younger than 21 years. The incidence of pediatric thyroid cancer has increased over the past half-century, and thyroid cancer is the third most common solid malignancy in children. [1] [2] [3] [4] Rates of malignancy in any given pediatric thyroid nodule exceed comparable rates in adults, reportedly as high as 40% historically and about 25% more recently. 1, 5, 6 Survival from pediatric thyroid cancer is excellent, with reported 30-year survival rates of 99% to 100% and 91% for papillary and nonpapillary thyroid carcinoma, respectively. 2, 7 Ultrasound plays a key role in screening several high-risk populations for thyroid cancer. For example, an era of liberal head and neck radiation for benign childhood conditions, spanning the 1940s to the early 1970s, placed many patients at high risk for subsequent thyroid malignancy. 8, 9 Another example is second primary cancers, which are those that develop after an initial cancer of any type. Most contemporary cases of second primary pediatric thyroid malignancy are attributed to prior head and neck radiation for malignancy or exposure to nuclear fallout. [10] [11] [12] [13] In contrast to the indolent and rarely fatal course of most primary thyroid malignancies, these secondary cancers are more likely to be multifocal at the time of diagnosis and confer a 3-to 6-fold higher risk of mortality.
Ultrasound in general is a cost-effective and noninvasive radiologic imaging modality that has been well studied in children and used for diverse medical conditions. Its application in pediatric thyroid disorders has been described, although much less extensively than for adult patients. Highlights of pediatric thyroid US findings can be found in recent national guidelines, original scientific publications, and book chapters. 1, [16] [17] [18] More recent investigations focused on the accuracy of modern US in diagnosing thyroid malignancy in children, as well as the implementation of screening US for thyroid cancer in higher-risk populations. 11, 13, 15, 19, 20 This article outlines, to our knowledge, the first comprehensive review of contemporary use of and advances in thyroid US as related to the diagnosis, treatment, screening, and surveillance of pediatric thyroid cancer. We also present the current understanding of US elastography and 3-dimensional (3D) US, as some hope these may provide options to avoid fine-needle aspiration biopsy (FNAB) in pediatric patients. Notably, the landmark 2015 American Thyroid Association (ATA) pediatric guidelines 1 summarized substantial accomplishments, including being the first such guidelines dedicated to childhood thyroid disease. In a comprehensive literature review, we found a paucity of specific commentary about the use of thyroid US in pediatric patients since their publication. The goal of our current article, therefore, is to fill that knowledge and communication gap and provide a comprehensive resource for how US applies to pediatric thyroid disease.
Review
High-Frequency Ultrasound Modern high-frequency US transducers are essential tools in the evaluation of the thyroid. The vast improvement in image quality over time allows for better delineation of malignant and benign features, as well as a more accurate assessment of growth over time (Figure 1 ). The anatomy of the thyroid and surrounding structures can be clearly delineated in both pediatric ( Figure 1A ) and adult ( Figure  1B ) patients. A summary of commonly visualized structures is delineated in Figure 1 , C-E.
The ideal transducer for head and neck US is a small linear transducer with a 10-12-MHz frequency. Ultrasound machines with a frequency as low as 7.5 MHz may provide adequate images, but it is the lowest acceptable frequency; likewise, US machines with up to a 15-17-MHz frequency are available, but a high frequency is not the only determinant of image quality. Newer US transducers use superior piezoelectric materials that resonate across wider bandwidths and at higher frequencies than those used in older models, producing dramatic improvements in resolution. 21 Incorporating a larger number of transducer elements has facilitated enhanced spatial compounding, or the formation of composite images from multiple angles ( Figure 1C ). Simultaneous frequency compounding, which relies on a range of frequencies distributed across the transducer bandwidth, further enhances image resolution. These changes cumulatively improve nodule margin delineation, assessment of size, and detection of smaller nodules. 21 Smaller transducers available on some US machines allow for better imaging in narrow regions, particularly in children ( Figure 2 ). This ability allows for a more accurate assessment of pediatric thyroid and neck anatomy and delineation of structures.
Advances in US contrast definition have further assisted with the determination of nodule consistency, reflectivity, and echogenicity, including foci of calcification and colloid. Signal processing, or "speckle reduction," improves the signal-to-noise ratio in images obtained by using pattern recognition to process lines of echoes on each frame. 21 The use of a dynamic grayscale range and the implementation of tissue harmonic imaging also improve sharpness and clarity. These developments are particularly helpful in the determination of "relative hyporeflectivity," or hypoechogenicty of a thyroid nodule relative to an adjacent strap muscle. Hypoechoic nodules in adults are categorized into the ATA high-risk classification because they are associated with a greater than 8-fold risk of malignancy. 22, 23 The end product of these US technologies is a sharper and clearer image with better-defined soft tissue densities. Figure 3 presents a comparison of US imaging of a malignant pediatric nodule on earlier ( Figure 3A ) versus more recent (Figure 3 , B-E) US models. This comparison underscores the improved diagnostic capabilities in identifying a benign, intermediate, or suspicious nodule with advances in US imaging technology.
Ultrasound Elastography and 3-Dimensional US Ultrasound elastography and 3D US are 2 developing technologies that show great promise in the evaluation of thyroid malignancy.
Though not yet well-studied in the pediatric population, they are presented here as they may become especially appealing to the pediatric population for the potential to avoid FNAB in children.
Ultrasound elastography, subdivided into strain elastography and shear wave elastography, is a developing tool that allows the objective measurement of tissue elasticity or stiffness. It is now available on many US machines, with older models assessing manual compression by the sonographer or transduced compression by carotid artery pulsation, whereas newer US machines Figure 1 . Thyroid anatomy by US. A, Normal thyroid anatomy on a transverse view in an 8-year-old child. B, Normal thyroid anatomy on a transverse view in a 45-year-old adult. There are no substantial anatomic structural differences except the depth of the location in the neck, as shown by the yellow numeric markers on the right frame. C, Normal anatomy on a transverse view of the thyroid with labeled structures: anterior layer of the deep cervical fascia (af), cervical spine, common carotid artery (CCA), esophagus (E, here seen in the less common position favoring the patient's right side of the midline), inferior thyroid artery (ITA), internal jugular vein (IJV), isthmus, midline raphe between strap muscles (MR), paraspinous muscles/longus colli muscle (PSM/LCM), platysma, right (RT) and left (LT) lobes of the thyroid, sternocleidomastoid muscle (SCM), sternohyoid muscle (SHM) sternothyroid muscle (STM), subcutaneous tissue (SQT), and trachea. D, Normal vascular anatomy shown on a transverse view of the thyroid with labeled structures. E, Typical anatomic distribution of normal superior and inferior parathyroid glands within dotted circles. Normal parathyroid glands are too small to be imaged by US, so only enlarged adenomas are evident in these locations.The right thyroid gland is shown in the longitudinal (sagittal) orientation. The superior thyroid artery (STA) is at the left of the image; the inferior thyroid artery is at the posterior midportion of the thyroid.
Ogle et al-Ultrasound in Pediatric Thyroid Malignancy J Ultrasound Med 2018; 00:00-00use US-induced radiation force impulses, which are integrated within the transducer. The latter technique allows for a more accurate assessment of relative tissue stiffness than compression or the carotid pulse. 24, 25 More than 100 preliminary studies of thyroid elastography have been published in adult populations, with the general consensus that papillary cancers have higher stiffness indices compared to benign nodules. 21 Strain elastography based on carotid artery pulsation appears to have higher overall accuracy (87%) in predicting malignancy than single or multiple conventional US criteria, with sensitivity and specificity of 86% and 89%, respectively. 26 Although not traditionally used in the neck, 3D US offers a potential paradigm shift for thyroid imaging in its ability to obtain more objective data. In a recent prospective study evaluating 91 adult thyroid nodules with 3D US, interobserver agreement on a particular nodule's malignant potential was increased with 3D images compared to 2-dimensional images. 27 Two new independent predictors of malignancy for 3D images were also identified (lobulated nodule shape in the coronal plane and altered central 3D vascularity). With the use of 3D images of thyroid nodules, a subsequent study developed an automated malignancy risk stratification system using computer-aided diagnostics. 28 Specific 3D textural features identified by the software program were used to differentiate accurately between benign and malignant nodules. Although this technology as applied to thyroid imaging and pediatric thyroid malignancy specifically remains relatively new, the ability to obtain objective textural and compositional data is appealing and warrants further investigation.
Diagnosis of Pediatric Thyroid Malignancy
Ultrasound is recommended for the primary evaluation of any new or previously identified biopsy-proven benign or indeterminate thyroid nodule in a child.
1 Current ATA guidelines recommend that FNAB be performed on lesions that show growth over time or display suspicious clinical or radiographic characteristics. These include hypoechogenicity, irregular margins, increased vascularity, microcalcifications, and the presence of abnormal cervical lymph nodes. Of note, the pediatric ATA guidelines recommend biopsy of nodules of any size with concerning features, a change from prior guidelines that mirrored those in adults, in recognition that size criteria can be problematic in children.
1,23
Figure 2. Small transducers are available from some US machine companies. A, These transducers facilitate imaging of narrow anatomic regions, especially in children, such as near the sternal notch and clavicles. B, The small linear footprint is less than 3 cm, compared to the larger transducer of nearly 5 cm in length. Small curvilinear transducers are also available and convenient for pediatric FNAB.
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As with the trailblazing contribution of the ATA pediatric guidelines, the 2015 revision of the ATA guidelines for the adult thyroid nodule and thyroid cancer management introduced for the first time a cancer risk classification hierarchy for thyroid nodules. 23 Given the relatively recent release of the ATA adult guidelines, they have yet to be prospectively investigated in adults, much less children, but these investigations are under way and will be available in a peer-reviewed publication soon. Reference to the ATA adult guidelines is included here because the US features of thyroid nodules and cancer do apply to children. 23 Thus, radiologists, endocrinologists, and surgeons (pediatric, otolaryngologists, and endocrine surgeons) who care for children with thyroid disorders should be familiar with these recent US advances in terms of nodule characterization and pattern recognition.
Authors who have reported on original and modern-day US machines have found that US alone cannot effectively differentiate between benign and malignant lesions. 16, 29 Although some US characteristics are commonly associated with benign versus malignant lesions, these have not been extensively validated in the pediatric population. 22, 30, 31 As such, and despite the inherent difficulty involved in procedural biopsy in a child, US-guided FNAB has been presented as a preferable and more accurate means of diagnosis for patients with possible malignancy than US alone. [32] [33] [34] [35] A recent Figure 3 . Examples of malignant thyroid nodules on US images from a pediatric patient. A, The right thyroid nodule (outlined) is a biopsy-proven papillary thyroid cancer imaged with an early-generation US system, showing a grainy texture and image quality. B, A left thyroid nodule detected on a modern US system with enhanced image quality reveals features of malignancy: indistinct borders and microcalcifications within the nodule (outlined) and enlarged, matted lymphadenopathy (arrows) lateral to the internal jugular vein (IJV). Fine-needle aspiration biopsy is required for definitive diagnosis. C-E, Other features of thyroid cancer: microcalcifications, irregular margins, and possible extension into the overlying sternothyroid muscle (C), a hypoechoic structure with a hint of an irregular margin (arrow in D), and broken eggshell calcification (E). Also shown in E is a smooth hyperechoic nodule that is benign. CCA indicates common carotid artery; and SCM, sternocleidomastoid muscle.
Ogle et al-Ultrasound in Pediatric Thyroid Malignancy J Ultrasound Med 2018; 00:00-0050-patient study explored the prospect of using high-risk US nodule features alone (without FNAB) to predict malignancy, observing 100% true-positive and 12% falsenegative rates. 36 It is also important to evaluate cervical lymph nodes with color Doppler imaging in any pediatric patient with suspected thyroid malignancy. A thin pinpoint Doppler signal located exclusively along the thin vascular hilum is the normal pattern of a benign lymph node. Lymph nodes harboring metastatic thyroid cancer have disordered vascularity, so an increased Doppler color signal is present along the periphery of the node as well as throughout the hypoechoic parenchyma of the node (which is otherwise avascular). These features, along with a rounded shape, microcalcifications, and a cystic component of a lymph node, are suspicious for malignancy and require further evaluation.
Compared to adults, pediatric thyroid patients may have unique US findings. For example, extensive cystic nodules in a goiter featuring colloid ring-down artifacts can be misinterpreted as microcalcifications (Figure 4) . Furthermore, young patients have prominent thymic tissue that can be misinterpreted as a mass ( Figure 5 ). The thymus in children is visible during surgery ( Figure 5 , C and D).
Most studies have reported high sensitivity and specificity of US-guided FNAB in evaluations for thyroid malignancy in children, with adequate cytologic sampling occurring in greater than 80% of FNABs. 31, 35, 37, 38 Importantly, certain US findings such as microcalcifications and coarse calcifications increase the odds of malignancy dramatically, up to 114 and 19 times, respectively. These are sometimes considered indications for surgery regardless of cytologic data. 39 Unlike adults, conducting FNAB does not reduce the number of patients undergoing thyroidectomy but prompts more aggressive resection for those with malignant or suspicious cytologic findings. 40 When taken in the context of a suspicious lesion, a benign or nondiagnostic FNAB finding has historically been viewed with trepidation. 5 Most of these patients are ultimately referred for surgery, as reflected in the current ATA guidelines and the appreciation that pediatric thyroid nodules have higher rates of malignancy than adults. 1 This factor further underscores the importance of experienced US interpretation and accurate pattern recognition, especially in the pediatric population, in which anxiety over a cancer diagnosis is even more pronounced for parents (Figure 4 ). Numerous US education venues are available for those clinicians who wish to enhance thyroid US skills and can be found via national professional societies (the American Association of Clinical Endocrinologists, which offers Endocrine Certification in Neck US, ATA, Endocrine Society, and American College of Surgeons).
An important role of cytology that is unique to children is to determine the extent of surgery in the case of indeterminate cytologic findings of malignancy. 39 In this subset of FNAB, diagnostic thyroid lobectomy (hemithyroidectomy) may be more reassuring for the ultimate diagnosis in pediatric patients. In this age group, limiting more radical thyroid surgery is always a consideration to Figure 4 . A colloid ring-down artifact occurs in cystic nodules and can sometimes be misinterpreted as microcalcifications.The US images represents a multicystic right thyroid (THY) goiter diagnosed in a 13-year-old girl who was referred for urgent needle biopsy to confirm suspected thyroid cancer, which produced unneeded anxiety in both the child and her parents. Because of the size of the goiter, surgery was performed and indeed confirmed a benign cystic goiter. A, Transverse view with a small triangular hyperechoic fragment, which is the only remaining normal right thyroid. B, Longitudinal (sagittal) view.
avoid potential surgical complications related to total thyroidectomy (eg, hypocalcemia) and the need for lifelong hormone replacement therapy. Furthermore, although molecular markers are used in conjunction with FNAB quite routinely now in adults, via both researchbased and commercially available assays, the same practice has not translated to the pediatric population 41, 42 largely because of the lack of evidence-based investigations of such assays in children, so that treating physicians can be reassured that they will not miss a pediatric thyroid cancer if surgery is avoided on the basis of molecular marker results.
43-45

Treatment of Pediatric Thyroid Malignancy
In addition to being a key modality in the diagnosis of pediatric thyroid malignancy, US imaging can play an important role in guiding its treatment. It is useful for defining laterality of the cancer within the thyroid, detecting multifocal disease, identifying lymph node metastases, and visualizing important anatomy of the thyroid and surrounding structures during the preoperative evaluation. The two key applications are to help define the extent of thyroidectomy and to help identify lymph node metastases before initial surgery, so that a single comprehensive operation to clear all cancer can ideally take place.
With regard to the extent of thyroidectomy, many clinical factors are considered, and the purpose of this review is not to examine those but to highlight the situations in which US informs that decision making. Interestingly, recent literature has found equivalent survival rates between lobectomy and subtotal or total thyroidectomy when performed for pediatric papillary thyroid cancer. 3, 7 This evidence has been duplicated in other large-scale retrospective studies that included follicular cell carcinoma. 46 Given the excellent survivability in the pediatric population and the trend toward performing surgery for all marginally suspicious lesions, it seems Figure 5 . Embryologic remnants seen in the pediatric thyroid on US imaging: thymus. A and B, On US images, the thymus is evident deep to the strap muscles and in the caudal part of the central neck near the clavicles in transverse (A) and longitudinal views (B). It can be misinterpreted as a "mass with microcalcifications." By the time of adolescence years or young adulthood, the thymus is no longer as prominently visible by US, even though it may still be visible during surgery. C and D, Anatomic appearance of the plump pale thymus tissue near the thyroid during surgery in an 11-year-old child during surgery (C) and in a 25-year-old adult (D), where the structure is substantially atrophied.
Ogle et al-Ultrasound in Pediatric Thyroid Malignancy J Ultrasound Med 2018; 00:00-00reasonable to consider that children with a suspicious solitary nodule on US in the absence of pathologic adenopathy, multifocal disease, or a predilection to more aggressive disease undergo lobectomy alone. This approach is in line with current ATA guidelines for incidentally discovered papillary thyroid carcinoma in pediatric lobectomy specimens, in which completion thyroidectomy is not required, and surveillance US is sufficient for further monitoring.
1 Therefore, the ability of US to exclude disease in the contralateral thyroid lobe is critical to surgical planning. It follows, also, that communication about US findings among the specialists (pediatrician, pediatric endocrinologist, radiologist, and surgeon) taking care of the patient is paramount.
Furthermore, lymph node mapping is an important step in the preoperative evaluation of a patient with thyroid malignancy. The levels of the neck are reviewed in Figure 6 for clarification and correlation with US findings at the corresponding levels. Pediatric patients tend to have more extensive lymphadenopathy, which underscores the importance of preoperative planning. Figure 7 shows cervical lymphadenopathy in an 11-year-old patient with metastatic papillary thyroid cancer as viewed by US ( Figure 7 , A and B) and intraoperatively ( Figure 7, C and D) . Intraoperative visualization of multiple relevant structures and redepiction of extensive lymphadenopathy in a pediatric patient are also available in the cited video. 47 Lymph node mapping is critical to achieve the ideal, comprehensive operation at the initial surgery. Thus, instead of a patient's facing diagnostic hemithyroidectomy, then completion total thyroidectomy, then lateral neck lymph node dissection, one carefully planned operation can address and clear the patient's disease.
Screening for Thyroid Cancer in Children
Ultrasound imaging is increasingly being incorporated into thyroid cancer screening in children. These patients can be divided into 3 general groups: patients being followed for autoimmune thyroiditis, children at higher risk for malignancy because of a history of radiation exposure, and those with familial cancer syndromes.
Autoimmune Thyroiditis
Although data are limited in children with autoimmune thyroiditis, a US examination is recommended for new nodules, growing nodules, substantial gland asymmetry, or clinically apparent cervical lymphadenopathy. 1 Investigators found an increased prevalence of thyroid nodules in children with autoimmune thyroiditis (30%), and a significant portion of them harbored malignancy; 64% of malignant nodules were missed on the physical examination and only appreciated by US. 48 Although routine screening with US is not recommended in these patients, or in those who only have hypothyroidism from thyroiditis, a clinically substantial glandular change should prompt an examination.
History of Radiation Exposure
Children who have had a history of malignancy, especially those who received head and neck radiation as part of their treatment, have a known increased risk of thyroid cancer as a second primary malignancy.
11 A higher rate of thyroid cancer is also observed in children who were exposed to environmental radiation. 13, 15 Both of these groups may benefit from US screening, although no standardized guidelines are available.
Thyroid cancers account for up to 11% of subsequent malignancies in survivors of childhood cancer. 49 Although the incidence of thyroid cancer peaks 15 to 25 years after the treatment of the original malignancy, Figure 6 . Levels of the neck are labeled according to the naming convention for surgery and for US lymph node mapping performed both during a preoperative evaluation and postoperative surveillance of thyroid cancer. Depicted are the submental triangle (level 1) and the anterior triangle, which includes high-jugular (level 2), mid-jugular (level 3), and low-jugular/supraclavicular (level 4) regions, the posterior triangle (level 5), the central neck (level 6), and the upper mediastinal region (level 7). The sternocleidomastoid muscle has a sternal head (solid line, ending in the sternal notch) and a clavicular head (dotted line), dividing the anterior from the posterior triangle. The cervical scar from prior total thyroidectomy for papillary thyroid cancer is visible in this 11-year-old child. The blue skin marker outlines the intended incision for lateral neck dissection of metastatic cervical lymph nodes, one of which is marked.
Ogle et al-Ultrasound in Pediatric Thyroid Malignancy increased rates of new cancers have been noted as soon as 5 to 15 years after the initial diagnosis. 49 The risk of subsequent thyroid cancer is particularly high in patients with a history of head and neck radiation or total body radiation in preparation for a bone marrow transplant.
A recent study of 119 pediatric survivors of childhood malignancy found a 10-fold increase in nodules larger than 1 cm in patients who had radiation to the thyroid gland in addition to chemotherapy compared with chemotherapy alone. Of the 33 total nodules larger than 0.3 cm that were found by US, 31 were not identified on the physical examination. The physical examination failed to identify any of the 11 nodules larger than 1 cm, including 2 nodules in the radiation group with suspicious US characteristics that were later diagnosed as malignancies requiring surgery. 12 Although the survivability of pediatric thyroid cancer is generally good, the risk of death associated with thyroid cancer when it has developed as a second primary malignancy is 3 to 6 times greater. 11 Such thyroid cancers are also more likely to be multifocal and smaller than 1 cm. 10 Although the physical examination remains the current standard of care for the detection of new thyroid nodules in pediatric patients being followed for any malignancy, increasing evidence points to the inadequacy of this modality and the need for standardized screening programs using US. Data from pediatric Chernobyl survivors in Belarus support this recommendation. 13 A mass-screening protocol and definition of baseline rates of thyroid malignancy were also established in Fukushima after the 2011 nuclear accident. 15 Several risk stratification models for predicting thyroid cancer as a second primary pediatric malignancy are now available and can be used to identify those at highest risk. 19 These include demographic data (birth year, sex, primary cancer type, and age at diagnosis) as well as self-reports of a previous thyroid nodule diagnosis, history of exposure to neck radiation, and history of exposure to an alkylating chemotherapeutic agent. Because regular annual US examinations in all survivors of pediatric malignancy may not be feasible, such models may prove helpful in identifying higher-risk populations who would benefit from US.
The 2015 ATA guidelines were unable to provide a definitive evidence-based recommendation on the necessity of US in the detection of subclinical nodules, citing a lack of available data on long-term outcomes. 1 However, these recommendations were made before publication of some of the more recent studies discussed above. Several factors relevant to the pediatric population nevertheless advocate for the logical practice of screening higherrisk groups with thyroid US. These include the higher rate of malignancy associated with subclinical thyroid nodules in survivors of childhood cancer, as well as in patients with a history of environmental radiation exposure, increased mortality rates from second primary cancers, and difficulty detecting small bilateral disease. Careful selection of the screening population using a risk prediction model will further help improve diagnostic and therapeutic yields.
Familial Differentiated Thyroid Cancer Syndromes
High-resolution US screening has become a mainstay of management for patients with known or suspected familial predilections for thyroid cancer. These include a wide assortment of entities, including nonsyndromic familial nonmedullary thyroid cancer, multiple endocrine neoplasia type 2 (MEN2), PTEN (phosphatase and tensin homolog) hamartoma tumor syndrome (PHTS or Cowden syndrome), APC (adenomatosis polyposis coli)-associated polyposis (including familial adenomatous polyposis [FAP] , Gardner syndrome, and Turcot syndrome), the Carney complex, Werner syndrome, Beckwith-Wiedemann syndrome, familial paraganglioma syndromes, Li-Fraumeni syndrome, McCune-Albright syndrome, and Puetz-Jeghers syndrome. [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] Approximately 3% to 10% of all nonmedullary thyroid cancers are associated with an inherited condition, and a patient with 1 or more first-degree relatives with nonmedullary thyroid cancer has a considerable likelihood of a familial and more aggressive form of disease. 63 The ATA recommends that all such patients be referred to centers of excellence for comprehensive evaluations.
Although US screening is not universally recommended for all patients with a suspected predisposition to disease, it appears to be beneficial in certain familial disorders. High-resolution US screening in family members of patients with nonsyndromic familial nonmedullary thyroid cancer has been associated with earlier stages of disease at diagnosis, a lower incidence of extrathyroidal extension (20.9% versus 56.2%), and a reduced incidence of nodal metastases (23.2% versus 65.6%). 64 Investigators recommend that US screening be offered to all first-degree family members of a suspected patient, regardless of the presence or absence of palpable disease, and that biopsy be obtained on all nodules of 5 mm or larger. Ultrasound screening should be initiated at age 20 years, or 10 years earlier than the youngest age of thyroid cancer diagnosis for the family. 59, 65 Annual screening with US is recommended for patients with Cowden syndrome, also known as PHTS. These patients have a 35% to 38% lifetime risk of developing thyroid cancer, with follicular cell carcinoma occurring more commonly than the papillary variety. Although the median age of thyroid cancer diagnosis in patients with PHTS is 35 years, a study of 36 patients revealed 6 cases of malignancy in patients younger than 18 years. 57 A diagnosis of follicular cell thyroid carcinoma in a pediatric patient should prompt consideration for genetic testing for PHTS, particularly in the setting of macrocephaly or a suggestive family history. 1 For both pediatric and adult patients with Cowden syndrome, US screening should begin at the age of diagnosis and repeat annually. 57, 61, 66 In our experience, US screening of children with PHTS was feasible in those as young as 2 years. Furthermore, an analysis demonstrated that thyroiditis and nodular changes can be detected and develop as soon as early adolescence. 67 Although a finalized screening program for thyroid cancer in patients with APC-associated polyposis has yet to be defined, multiple authors have suggested intermittent US examinations, possibly to coincide with gastrointestinal surveillance. 20 Thyroid malignancies detected by US in patients with FAP, a subset of APC-associated polyposis, are generally smaller and with fewer associated recurrences, surgical complications, and cancer-related deaths. 68 Total thyroidectomy is nonetheless indicated in the patient with FAP and malignancy or symptomatic benign disease given the high likelihood of multifocal disease (80%-100%). 20, 68 More than 90% of childhood medullary thyroid carcinoma cases are due to MEN2. 69 It is the most frequent cause of death in patients with MEN2, and total thyroidectomy before metastatic disease develops is the only curative treatment. Improved knowledge regarding the genotype-phenotype correlation now allows geneticists to classify MEN2 patients into 1 of 3 risk levels (ATA moderate risk, high risk, and highest risk). 70 For patients with lower-risk mutations (moderate), it is acceptable to delay prophylactic total thyroidectomy in exchange for expectant monitoring with serial serum calcitonin levels and annual thyroid US. 70 Higher-risk mutations are increasingly being managed by this algorithm as well. 71 Although there is little debate about the ultimate necessity for total thyroidectomy in most children with MEN2, US helps guide the optimal timing of thyroidectomy to balance risks of disease development with risks of surgical complications that are higher and more undesirable at earlier ages. Children older than 3 years with thyroid nodules smaller than 0.50 cm on high-quality US imaging and calcitonin levels of less than 30 to 40 pg/mL are unlikely to have metastatic disease. 71, 72 Close surveillance including annual US spares unnecessary urgent surgery and its related complications in children with a low likelihood of imminent clinically relevant disease.
Surveillance for Thyroid Cancer Recurrence
Ultrasound is the imaging modality of choice for postoperative surveillance of pediatric patients with a history of thyroid malignancy. Because survival from pediatric thyroid cancer is so favorable, recurrence remains a lifetime risk. The anatomic regions surveyed to detect recurrence include the central neck (thyroid bed) and lateral neck, with lymph node mapping of the levels illustrated in Figure 6 . Based on current ATA guidelines, stratification into risk-of-recurrence categories (low, intermediate, and high) helps guide the frequency of US. Neck US is recommended at 6 months postoperatively for children with thyroid cancer as well as at 6-month intervals subsequently for children in the intermediate-and high-risk groups and at 6-to 12-month intervals for those in the low-risk category. 1 
Summary
Modern US plays a central role in the evaluation of pediatric thyroid malignancy. Advances in US technology and the production of higher-quality images have facilitated better characterization of benign and malignant disease patterns. There is now greater reliance on US in the diagnosis of thyroid cancer in children, with or without image-guided FNAB. Further advances in US imaging, namely elastography and 3D US, promise to bring additional diagnostic power to this modality.
As a screening tool and surveillance mechanism for thyroid cancer in high-risk pediatric populations, US is clearly superior to the physical examination. Ultrasound is a useful modality in the treatment of children and adolescents with select familial thyroid cancer syndromes, including familial nonmedullary thyroid cancer, FAP, Cowden syndrome/PHTS, and MEN2. Several validated absolute risk prediction models for secondary thyroid cancer in survivors of pediatric malignancy are now available that can help target screening efforts. Further research on the clinical importance of screening programs associated with these models is certainly indicated.
Limitations to the use of high-frequency thyroid US in the pediatric population include accessibility and the need for a skilled sonographer with pediatric expertise or care at centers of excellence. Pediatric patients with major thyroid disease generally receive care from specialized pediatric endocrinologists or endocrine surgeons. Increasing numbers of these providers receive training in clinic-based US and interpretation of US images, which helps streamline the diagnostic pathway. 73, 74 Ogle et al-Ultrasound in Pediatric Thyroid Malignancy J Ultrasound Med 2018; 00:00-00
Conclusions
Ultrasound is a key modality in the treatment of pediatric patients who are at risk for or already have a diagnosis of thyroid cancer. Modern advances in US technology allow for better imaging quality and characterization of lesions. In addition to its utility in the diagnostic workup, guidance in the extent of treatment selection, and surveillance for recurrence in patients with primary thyroid malignancy, US plays a central role as a convenient and noninvasive screening tool. This role is exceptionally relevant to special pediatric populations at high risk for radiation-associated thyroid cancers, hereditary thyroid cancer syndromes, and thyroid cancers that develop as second primary malignancies after a patient has already had another type of childhood cancer. Opportunities for future advancement of patient care exist in the form of continued research into novel US imaging technologies, prospective studies evaluating the efficacy of US alone in suggesting malignancy and guiding related therapy, the application of molecular markers with FNAB, and further investigation into the optimum management algorithms for US detection of subclinical cancers in appropriate patient populations. As advocates of surgeon-and clinician-performed US examinations, we also encourage any activity among pediatric specialists that will increase awareness, skill, and familiarity with US imaging of their patients with thyroid disease.
